Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYNE2 (Spectrin repeat containing nuclear envelope protein 2) encodes nesprin-2, a large, modular protein located in the outer nuclear membrane that binds cytoplasmic F-actin. Nesprin-2 is a key component of the LINC complex, which physically links the nuclear envelope to the cytoskeleton, thereby maintaining nuclear architecture and regulating nuclear movement in numerous cell types. This connection facilitates mechanotransduction, nuclear positioning, and migration. SYNE2's interactions with inner nuclear membrane proteins (such as emerin, lamins, SUN proteins), actin-binding proteins, and motor adaptors underpin its structural and regulatory functions. Pathogenic mutations in SYNE2 are implicated in autosomal dominant Emery-Dreifuss muscular dystrophy and nuclear envelope-related disorders, and genetic variation in SYNE2 can affect cancer outcomes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spectrin repeat containing nuclear envelope protein 2 (SYNE2).